Unjha Formulations Ltd
₹0.00▲ +0.00 (+0.00%)
UNJHAFORMULATIONSLTD·NSE·Healthcare
Market Cap
15.10 Cr
PE Ratio
32.10
Volume
—
Day High - Low
—
52W High-Low
36.38 - 17.52
₹0.00▲ +0.00 (+0.00%)
Market Cap15.10 Cr
PE Ratio32.10
Volume—
Day High - Low—
52W High-Low36.38 - 17.52
Unjha Formulations Ltd (UNJHAFORMULATIONSLTD): company summary
Unjha Formulations Ltd (UNJHAFORMULATIONSLTD) is a micro-cap Healthcare company valued at ₹15 crore operating in Pharmaceuticals on the NSE and BSE.
Unjha Formulations Ltd (UNJHAFORMULATIONSLTD) is a micro-cap Healthcare company valued at ₹15 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing steadily at 6.1% a year over three years; profit grew 35.7% a year, ahead of revenue — margins are expanding. Return on equity is 20.1%.
- Valuation multiples
- The stock trades at 32.1 times earnings, broadly in line with the Healthcare median of 32.0, 3.93 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
5.4/10
Weak
Fair Value
Sign in to see
ROE
20.10%
Strong
P/E
32.10x
Fair
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹17.52
₹36.38
DocStoX take
Supported by growth (8.0) and quality (6.3), but held back by valuation (2.0). Growth looks strong at 8.0, but that is offset by valuation at 2.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence5.4
/10
Weak
Quality
Solid
ROE 20.1%
Valuation
Expensive
P/E 32.1×
Growth
Strong
Revenue +9.5% 5Y CAGR
Risk
Moderate
D/E 0.00
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹15 Cr
52W High / Low
₹36 / ₹18
Dividend Yield
0.00%
Promoter Holding
36.92%
EPS (TTM)
₹0.92
Book Value
₹8.58
Key highlights
- Profit compounding 48% a year
- Low leverage — D/E 0.00
- Profitable in all of the last 5 years
- Valuation is weak (2.0/10)
- Small ₹15 cr company — thinner liquidity
4 Positives2 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Unjha Formulations Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Unjha Formulations Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Unjha Formulations Ltd with peers
Unjha Formulations Ltd vs Sun Pharmaceutical Industries LimitedUnjha Formulations Ltd vs Divi's Laboratories LimitedUnjha Formulations Ltd vs Torrent Pharmaceuticals LimitedUnjha Formulations Ltd vs Apollo Hospitals Enterprise LimitedUnjha Formulations Ltd vs Zydus Lifesciences LimitedUnjha Formulations Ltd vs Laurus Labs Limited
Related tools & concepts
Value Unjha Formulations Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing